ResMed Inc (RME.HA)
Hanover - Hanover Delayed Price. Currency in EUR
Add to watchlist
As of 08:01AM CEST. Market open.
| Previous Close | 174.45 |
| Open | 173.80 |
| Bid | 173.40 x N/A |
| Ask | 176.95 x N/A |
| Day's Range | 173.80 - 173.80 |
| 52 Week Range | 127.55 - 202.30 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Omnicell (OMCL) Banks on Product Launches, Global Growth
Omnicell (OMCL) remains a key player in automating and modernizing global medication management infrastructure.
- Zacks
Zacks.com featured highlights include ResMed, Badger Meter, Leidos and Ingersoll Rand
ResMed, Badger Meter, Leidos and Ingersoll Rand are part of the Zacks Screen of the Week article.
- Zacks
Thermo Fisher (TMO) Brings Biobased, Sustainable Films for BPCs
Thermo Fisher (TMO) has launched biobased solutions to help reduce the climate impact on the manufacturing of therapies.
© 2024 Yahoo. All rights reserved.